Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness study

Chouaid, C., Danson, S. orcid.org/0000-0002-3593-2890, Andreas, S. et al. (15 more authors) (2018) Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness study. Lung Cancer, 124. pp. 310-316. ISSN 0169-5002

Abstract

Metadata

Authors/Creators:
  • Chouaid, C.
  • Danson, S. https://orcid.org/0000-0002-3593-2890
  • Andreas, S.
  • Siakpere, O.
  • Benjamin, L.
  • Ehness, R.
  • Dramard-Goasdoue, M.-H.
  • Barth, J.
  • Hoffmann, H.
  • Potter, V.
  • Barlesi, F.
  • Price, M.
  • Chirila, C.
  • Hollis, K.
  • Sweeney, C.
  • Wolowacz, S.
  • Kaye, J.A.
  • Kontoudis, I.
Copyright, Publisher and Additional Information: © 2018 GlaxoSmithKline Biologicals SA. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).
Keywords: Adjuvant therapy; Burden-of-illness; NSCLC; Observational study
Dates:
  • Accepted: 30 July 2018
  • Published (online): 10 August 2018
  • Published: October 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 24 Sep 2018 13:52
Last Modified: 10 Oct 2018 13:08
Published Version: https://doi.org/10.1016/j.lungcan.2018.07.042
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.lungcan.2018.07.042
Related URLs:

Share / Export

Statistics